Axios Pro Exclusive ContentPathos AI raises $365M at $1.6B valuationIllustration: Gabriella Turrisi/AxiosPathos AI, a New York drug development startup, raised $365 million in a Series D at a $1.6 billion valuation. Why it matters: The round represents investors' continued interest in platforms using AI for drug development.Follow the money: The financing brings Pathos AI's total funding to around $467 million, per PitchBook data.Pathos AI did not disclose Series D investors. Backers in prior ro...